NEURONES: Declaration Of Transactions On Treasury Shares (March 30 To April 3, 2026)

2026-04-07 06:15:57

(MENAFN- GlobeNewsWire - Nasdaq) Nanterre, April 7, 2026

Declaration of transactions on treasury shares
(period from March 30 to April 3, 2026)

As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 30 and April 3, 2026 (ISIN code FR0004050250):

Day	Total daily volume (in number of shares)	Weighted average price (unit daily)
03/30/2026	25,500	34.36 €
03/31/2026	31,694	35.19 €
04/01/2026	17,922	36.00 €
04/02/2026	3,636	35.83 €
04/03/2026	-	-
Total	78,752

As of April 3, 2026, excluding the liquidity contract, NEURONES now holds 309,613 of the 24,328,716 shares comprising the company's capital (i.e., 1.27%).

All press releases relating to the share buyback program are published in the "Regulated Information" section (under "Weekly declarations of the share buyback transactions" and "Share buyback programs") of the company's website.

About NEURONES

With over 7,300 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, embrace AI, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03
...

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
...

Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
...

Attachment

neurones-weekly-declaration-transactions-treasury-shares-march-30-to-April-3-2026

MENAFN07042026004107003653ID1110950996

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.